Pacira Pharmaceuticals's total assets for Q2 2026 were $1.24B, an increase of 2.93% from the previous quarter. CH:82P total liabilities were $572.01M for the fiscal quarter, a 3.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.